SFN and non-small cell lung carcinoma: The results showed that the expression of SFN in NSCLC patients that had a good prognosis was significantly lower than the expression of SFN in NSCLC patients that had a poor prognosis from the GSE14814 dataset (p = 0.017; Figure 4D).